Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05168163
Title Atezolizumab in Combination With a Multi-Kinase Inhibitor for the Treatment of Unresectable, Locally Advanced, or Metastatic Liver Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Academic and Community Cancer Research United
Indications

hepatocellular carcinoma

Therapies

Atezolizumab + Cabozantinib

Cabozantinib

Atezolizumab + Lenvatinib

Lenvatinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.